factor, creator, conditor — Observations on the Impact of the Septuagint on the Vocabulary of Creation in the Latin Bible
Studia Universitatis Babeș-Bolyai Sacra Scripta · 14.05.2026 · 71-88
DOI: 10.24193/sacrascripta.2024.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studia Universitatis Babeș-Bolyai Sacra Scripta, online erschienen am 14.05.2026. Verfasst von Eberhard BONS. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The aim of this article is to study the Latin terminology of creation used in the Vulgate and in Jerome’s commentary on the biblical writings. The following questions will be addressed: 1o Which words or word groups are Jerome’s favourite terms when it comes to speaking of God as the creator and the creation? 2o To what extent can we explain these terminological choices against the background of the Greek Bible or an already-existing Latin theological terminology attested in the Vetus Latina or in other Latin speaking authors? To what degree is Jerome influenced by the Hebrew biblical text? 3o Is Jerome aware of the specific connotations of the various terms referring to the creator and the creation and, if yes, does he make any observations in this regard?
Zitieren
APA
BONS, E. (2026). factor, creator, conditor — Observations on the Impact of the Septuagint on the Vocabulary of Creation in the Latin Bible. Studia Universitatis Babeș-Bolyai Sacra Scripta, 71-88. https://doi.org/10.24193/sacrascripta.2024.03
Vancouver
BONS E. factor, creator, conditor — Observations on the Impact of the Septuagint on the Vocabulary of Creation in the Latin Bible. Studia Universitatis Babeș-Bolyai Sacra Scripta. 2026:71-88. doi:10.24193/sacrascripta.2024.03
BibTeX
@article{BONS2026,
author = {BONS, Eberhard},
title = {factor, creator, conditor — Observations on the Impact of the Septuagint on the Vocabulary of Creation in the Latin Bible},
journal = {Studia Universitatis Babeș-Bolyai Sacra Scripta},
year = {2026},
pages = {71--88},
doi = {10.24193/sacrascripta.2024.03}
}
EUVIMED